top of page

Search Results

Results found for "GPCR podcast"

  • 📰 GPCR Weekly News, May 20 to 26, 2024

    GPCR contributor article Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted GPCR University workshop on Advanced Data Analysis for GPCR Pharmacology, led by the esteemed Dr. GPCR Podcast We have thrilling news—Episode 153 of the Dr. GPCR Podcast featuring Dr. Titled "Embracing Networking for Professional Growth" Our podcast episodes are now available in video GPCR Ecosystem

  • A Note from Yamina: Building the Next Chapter of Dr. GPCR

    GPCR. Dear Dr. GPCR, it was with a simple goal: to connect people who shared a passion for GPCR science and discovery Strengthening the Foundation You already know our Free Ecosystem  — the podcast, blogs, and Flash News GPCR About Dr. GPCR Dr. From free resources like the podcast and blog to our Premium ecosystem and Foundry initiatives, our mission

  • 📰 GPCR Weekly News, June 3 to June 9, 2024

    GPCR Podcast The 155th episode of the Dr. GPCR Podcast features a recap of the Endocrine Metabolic GPCRs 2024 with the organizers, Drs. Adhesion GPCR Consortium: The 11th Adhesion GPCR Workshop. Drug Discovery Platform GPCRs and Emotional Pain: Exploring Non-Narcotic Pathways to Relief GPCR Events GPCR Ecosystem

  • Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?

    In the high-stakes world of GPCR drug discovery , breakthrough science isn't enough. GPCR, we recognized this core problem. This is the essence of de-risking GPCR programs through operational excellence. the entire GPCR program as a single, interconnected entity. The GPCR Precision Blueprint is more than a concept.

  • Posttranslational modifications in GPCR internalization

    August 2022 "G protein-coupled receptors (GPCRs) are the largest family of membrane receptors that serve Classically, GPCR internalization has been considered to lead to receptor desensitization. Here, this review summarizes different PTMs in GPCR internalization and analyzes their significance in , which will offer new insights into the regulatory mechanism of GPCR signaling and novel drug targets Read more at the source #DrGPCR #GPCR #IndustryNews

  • Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal

    Why Speed Matters in GPCR Drug Discovery Nine out of ten GPCR programs stall  not because the target In accelerating GPCR drug discovery, the bottleneck isn’t target identification — it’s turning validated GPCR Kinetics: The Critical Data You Can’t Afford to Skip Equilibrium potency data only tells part of “GPCRs are nature’s prototype allosteric proteins. Everything they do is allosteric.” Kenakin with your own enzyme or GPCR interaction puzzles.

  • Illuminating the draggable GPCR-ome

    GPCR Virtual Cafe. This time with none other than Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

  • 📰 GPCR Weekly News, May 27 to June 2, 2024

    GPCR Podcast Episode 154 of the Dr. GPCR Podcast on Self-Learning, Collaboration, and Delegation in Science with Dr. You can now watch podcast episodes in video format on our website. GPCR Consortium: The 11th Adhesion GPCR Workshop will take place in vibrant Mexico City from October GPCR Ecosystem

  • Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence

    Elevate Your GPCR Science with Essential Frameworks for Precision Drug Discovery: An Insight into Advanced GPCR-Based Drug Discovery conference is where the future of GPCR therapies will be defined. GPCR Premium Membership Gives You an Edge In a world filled with noise, Dr. GPCR Premium Membership delivers curated, noise-free intelligence every week. The pace of GPCR innovation is accelerating.

  • Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right

    Fluorescent probes illuminate the mysteries of GPCRs in cutting-edge research. Hi GPCR Community, If you work on GPCR discovery, you already know: early signals can mislead, and timing GPCR Premium: Sneak Peek A fast, editorial preview—enough to guide your attention, not replace your due Track, GPCR Happy Hour, and more! GPCR innovation is accelerating.

  • How a Failed Experiment Created a Powerful GPCR Imaging Tool

    Broichhagen aka JB, the goal was bold and elegant: Create a photo-switchable ligand to remotely control GPCR They had a tool that did bind the GPCR… but not in the light-controlled way they wanted. The Moment a Failed Tool Became a GPCR Imaging Breakthrough What the compound did reliably do was label This solved a long-standing problem in GPCR biology: You can't understand signaling if you can’t see  The Larger Lesson for Scientists and Innovators This story isn’t just about a GPCR imaging tool.

  • Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research

    GPCRs are one of the most important families of therapeutic targets in the pharmaceutical industry Approximately one-third of the drugs currently in clinical use are GPCR ligands. The C5a anaphylatoxin chemotactic receptor 1, also known as CD88, is part of the rhodopsin family of GPCRs and C5aR-Chem1 (DiscoverX) transfected cell lines, along with the cAMP HunterTM eXpress C5aR CHO-K1 GPCR Trends in GPCR Drug Discovery: New Agents, Targets and Indications.

  • 📰 GPCR Weekly News, May 6 to 12, 2024

    GPCR Podcast Episode #151 is out! A special episode with our board, meet Drs. GPCR Podcast? Join us in this episode to meet the team behind Dr. GPCR Summit. GPCR in-person event. GPCR Ecosystem

  • Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!

    Take a look at our GPCR coverage for this week. We've got 11 GPCR papers, seven industry news pieces, a new GPCR event, and even a job ad.   with real-time kinetics Discovering new ligands and GPCR behaviors for unique drug profiles   GPCR Event Let’s dive into the   Classified GPCR News  from July 29th to August 4th, 2024 GPCR Activation and Signaling GPCR Ecosystem

  • From Farm Fields to GPCR Discovery, GLP-1 and GIP

    Following the Data Into GPCR, Metabolic Disease and GLP-1 After his PhD, Hodson entered neuroendocrinology GPCRs Re-Enter the Story — Not as Theory, but as Tools GPCRs have always been powerful drug targets — That partnership eventually produced fluorescent GPCR tools  that allow researchers to visualize GPCR Emerging direction: Multi-target GPCR + myostatin-pathway combinations. Can GPCRs act as “delivery ZIP codes” for targeted therapies?

  • Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools

    GPCR, the global knowledge hub for G protein-coupled receptor (GPCR) research and education, is proud GPCR Newsletter , University Courses , and Podcast , as well as the searchable Dr. GPCR. GPCR Dr. With over 160 podcast episodes, live and on-demand educational programs, and a dynamic partner ecosystem

  • The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology

    explicitly interested in GPCR signaling... but the thing about GPCRs... is you always kind of end up landing at a GPCR as a major target." GPCRs in the Background, But Always Present Even though his primary focus wasn’t GPCRs themselves, Serafini Takeaway Forget what you think you know about GPCR drug targets. data platform , GPCR training program , pain research , opioid signaling .

  • Targeting Intracellular Allosteric Sites in GPCRs

    Exploring the intracellular allosteric site GPCRs represent one of the largest and most vital families For this reason, GPCRs have been a focus of drug development for decades due to their role in regulating Conventional GPCR drug discovery has largely focused on orthosteric sites, but recent breakthroughs in GPCR activity, enabling greater specificity and fewer side effects. allosteric site common in class A and class B GPCRs, particularly in chemokine receptors.

  • How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)

    Exploring the Hidden Dynamics: How Kinetics Reveals What Equilibrium Conceals in GPCR Research. Hi GPCR Community, If equilibrium curves are your comfort zone, this week’s feature will challenge (and GPCR Premium: Sneak Peek Here’s a fast, high-level preview of what Premium Members are unpacking this We’ve got your GPCR Track, Happy Hour, and sessions mapped so you can extract maximum value. GPCR innovation is accelerating.

  • First AMA of 2026: GPCR Pharmacology, Biased Signaling & Mechanistic Clarity

    2026 GPCR Pharmacology AMA: Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology as new videos are released: ▶️ https://www.youtube.com/@TerryPharmacologyCorner New White Paper on GPCR School of Medicine, has authored a new white paper in collaboration with Eurofins DiscoverX: Assess GPCR ) Systematic comparison of biased agonists using modern functional assays For scientists working in GPCR Forty years of pharmacological expertise — organized into a year-round framework for serious GPCR scientists

  • Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology

    In GPCR drug discovery, a single mistaken assumption can derail an entire program. Why Misreading Antagonism Delays GPCR Drug Discovery If a dose-response curve shifts to the right, you Why now:  GPCR research is accelerating—and the projects that succeed will be those built on clear, accurate

  • Dr. Rosie Dawaliby Podcast!

    GPCR podcast! 🥁 Drum rolls, please! Our guest is the wonderful Dr. Rosie Dawaliby! GPCR Ecosystem paid membership ➡️ https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ep-84-with-rosie-dawaliby #gpcr #drgpcr

  • Join the #GPCR movement today!

    GPCR Ecosystem paid membership with extra benefits? Create your own group, watch the latest podcast video before everyone else or start a discussion in the 🔬Join the #GPCR movement today! ➡️ https://www.ecosystem.drgpcr.com/plans-pricing #gpcr #drgpcr

  • Single-molecule counting applied to the study of GPCR oligomerization

    Read more at the source #DrGPCR #GPCR #IndustryNews

  • Community guidelines for GPCR ligand bias: IUPHAR review 32

    August 2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third Read more at the source #DrGPCR #GPCR #IndustryNews

  • How GPCR Collaboration Built an Innovation Engine

    What emerged wasn’t just another pharmacology group — it became a collaborative engine for GPCR discovery The Power of GPCR Collaboration: Funding as a Force Multiplier Collaboration sounds warm and fuzzy. This ecosystem outlasted individual PIs  and became a GPCR innovation hub  with global reach. GPCR science thrives in complexity — meaning no single lab or company can do it alone. GPCR Premium  for deep dives, strategic tools, and behind-the-scenes conversations shaping the GPCR field

  • Exploring the Breakthroughs in GPCR Research

    📰 GPCR Weekly News, July 8 to 14, 2024 Hello readers! Check out our GPCR coverage for this week. We have 15 GPCR papers, three industry news, and two job ads. GPCR Event Highlight 11th Adhesion GPCR Workshop Hosted by the Adhesion GPCR Consortium, this event will Let’s dive into the Classified GPCR News from July 8th to 14th, 2024 GPCR Activation and Signaling GPR116 GPCR Ecosystem

  • Quantifying the kinetics of GPCR signaling

    Join us and learn how to quantify your kinetic GPCR signaling from the expert himself: Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

  • Diversity and specificity in location-based signaling outputs of neuronal GPCRs

    August 2022 "The common mechanisms by which members of the G protein-coupled receptor (GPCR) family respond However, it is becoming increasingly clear that GPCRs show great diversity in their intracellular location Here we will discuss recent studies on the diversity of location, effectors, and signaling of GPCRs, and how these could interact to generate specific spatiotemporal patterns of GPCR signaling in cells. Read more at the source #DrGPCR #GPCR #IndustryNews

  • GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions

    GPCR activation typically occurs through the binding of agonists which stabilize receptor conformations GPCR targeting drugs: orthosteric vs allosteric sites Most of the drugs targeting GPCRs bind to the orthosteric GPCRs functional selectivity Recent research has revealed a more intricate understanding of GPCR behavior Agonist binding to GPCRs doesn't always trigger all associated events sequentially. selectively activate specific cellular outcomes linked to that GPCR.

bottom of page